MHRA-101103-PIP01-23

Key Facts

Active Substance
Active Substance:
  • FINERENONE
Invented Name
  • Kerendia
  • Kerendia
PIP Number MHRA-101103-PIP01-23
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate formulation
Therapeutic area
Therapeutic area:
  • Cardiovascular Diseases
Conditions / Indications
Conditions / Indications:
  • Treatment of heart failure
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):FINERENONE.pdf
Published Date 24/06/2024